LifeMD, Inc. Reports Strong Q3 2025 Results

Lifemd, Inc. ( (LFMD) ) has released its Q3 earnings. Here is a breakdown of the information Lifemd, Inc. presented to its investors.

LifeMD, Inc. is a prominent provider of virtual primary care services, offering telemedicine and pharmacy solutions across a wide range of health conditions. The company is known for its vertically integrated digital care platform and extensive reach across the United States.

In its third-quarter 2025 earnings report, LifeMD announced a 13% increase in total revenue, reaching $60.2 million, and a 20% rise in adjusted EBITDA to $5.1 million. The company highlighted its successful debt payoff and the divestiture of its majority stake in WorkSimpli, reinforcing its focus on telehealth and pharmacy services.

Key financial metrics from the report include an 18% growth in telehealth revenue to $47.3 million and a 30% increase in telehealth adjusted EBITDA to $2.9 million. The number of active telehealth subscribers rose by 14% to approximately 310,000. The company also achieved a significant milestone with the regulatory approval of its compounding pharmacy in Pennsylvania, enhancing its service capabilities.

LifeMD’s strategic moves, such as diversifying its clinical platform and strengthening its balance sheet, position it well for future growth. The company is expanding its offerings in behavioral health, women’s and men’s health, and personalized therapies, which are expected to drive further growth in 2026.

Looking ahead, LifeMD’s management remains optimistic about the company’s growth prospects, supported by a robust balance sheet and an increasingly diversified service platform. The company anticipates continued expansion in its telehealth business and aims to capitalize on evolving market trends in the coming year.